GTS Securities’s Insmed INSM Stock Holding History

GTS Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,600	Closed	-$1.07M	–	2603
2024 Q3	$1.07M	Sell	14,600 -4,900	-25%	-$362K	﹤0.01%	2105
2024 Q2	$1.31M	Buy	+19,500	New	+$756K	﹤0.01%	1831

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GTS Securities's INSM Position: Q1 2026 in Review

GTS Securities opened a new position in Insmed (INSM) in Q1 2026: 1,991 shares worth $326K. The stake represents 0.01% of the portfolio and ranks #1038 among its holdings. This is a return to the name: GTS Securities previously reported a position in INSM as recently as Q4 2024.

GTS Securities first reported a position in INSM in Q2 2024 and has held it in 3 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

GTS Securities held 1,991 shares of Insmed worth $326K as of Q1 2026.
Insmed was a new GTS Securities position in Q1 2026.
Insmed made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1038 holding.
GTS Securities first reported a position in Insmed in Q2 2024 and has held it in 3 quarters since.
670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.